1 emprego da associação tetraciclina e quinino no tratamento da malária causada pelo plasmodium falciparum

2 risks of plasmodium falciparumparasitemia among 10 years or below children in indonesia: a 2010 national study

3 plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies

4 Plasmodium falciparum PFI1625c offers an opportunity to design potent anti-malarials: Biochemical characterization and testing potentials in drug discovery.

5 The search for plasmodium falciparum histidine-rich protein 2/3 deletions in Zambia and implications for plasmodium falciparum histidine-rich protein 2-based rapid diagnostic tests

6 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

7 Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia

8 Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014

9 Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

10 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

11 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

12 Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria

13 Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia

14 Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014

15 Multiple-Strain Malaria Infection and Its Impacts on Plasmodium falciparum Resistance to Antimalarial Therapy: A Mathematical Modelling Perspective

16 Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

17 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

18 Socioeconomic Risk Factors for <i>Plasmodium falciparum</i> Infection in Primary School Children in Three Districts of the Volta Region Of Ghana.

19 Correction: Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

20 Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

21 Extracellular vesicles carrying lactate dehydrogenase induce suicide in increased population density of Plasmodium falciparum in vitro

22 Characterization of the accessible genome in the human malaria parasite Plasmodium falciparum.

23 High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.

24 Efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a protocol for systematic review and individual patient data (IPD) meta-analysis.

25 Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

26 Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.

27 Pregnant Women: An Overlooked Asset to Plasmodium falciparum Malaria Elimination Campaigns?

28 Spatial mapping and prediction of Plasmodium falciparum infection risk among school-aged children in Côte d'Ivoire.

29 Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand.

30 Assessment of the Combined Effect of Epstein–Barr Virus and Plasmodium falciparum Infections on Endemic Burkitt Lymphoma Using a Multiplex Serological Approach

31 Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity.

32 Infants' Peripheral Blood Lymphocyte Composition Reflects Both Maternal and Post-Natal Infection with Plasmodium falciparum.

33 Synthesis and anti-Plasmodium falciparum evaluation of novel pyrazolopyrimidine derivatives

34 Pan-Plasmodium band sensitivity for Plasmodium falciparum detection in combination malaria rapid diagnostic tests and implications for clinical management.

35 Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda.

36 Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection.

37 Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia.

38 Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.

39 Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for <it>Plasmodium falciparum </it>malaria in a hyperendemic region of Uganda

40 Stabilization of chloroquine resistance in vivo of plasmodium falciparum in edea, south cameroon

41 Increase of chloroquine resistance in vivo of plasmodium falciparum over two years in edea, South Cameroon

42 In vivo study of amodiaquine sensitivity of Plasmodium falciparum in the town of Edea (Cameroon)

43 Asymptomatic falciparum malaria and intestinal helminths co-infection among school children in Osogbo, Nigeria

44 An Exported Heat Shock Protein 40 Associates with Pathogenesis-Related Knobs in Plasmodium falciparum Infected Erythrocytes

45 Prevalence of afebrile parasitaemia due to Plasmodium falciparum & P. vivax in district Balaghat (Madhya Pradesh): Implication for malaria control

46 Plasma cytokines, chemokines and cellular immune responses in pre-school Nigerian children infected with <it>Plasmodium falciparum</it>

47 Assessment of Antimalarial Activity against Plasmodium falciparum and Phytochemical Screening of Some Yemeni Medicinal Plants

48 The recognition of proteasomal receptors by Plasmodium falciparum DSK2.

49 Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.

50 Regioselective synthesis of 2-chloroquinoline based ethyl 4-(3- hydroxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3- carboxylates and their in-silico evaluation against P. falciparum lactate dehydrogenase.

51 Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum

52 Synthesis of new 4-Aminoquinolines and evaluation of their in vitro activity against chloroquine-sensitive and chloroquine-resistant plasmodium falciparum

53 Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum

54 The multifaceted histone chaperone RbAp46/48 in Plasmodium falciparum: structural insights, production, and characterization.

55 Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin.

56 The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection

57 Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia

58 Plasmodium falciparum and Helminth Coinfection in a Semiurban Population of Pregnant Women in Uganda

59 Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia

60 Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children

61 Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso

62 Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

63 Out of Africa: origins and evolution of the human malaria parasites Plasmodium falciparum and Plasmodium vivax

64 Loss of cellular immune reactivity during acute Plasmodium falciparum malaria

65 A Prospective Comparative Study of Knowlesi, Falciparum, and Vivax Malaria in Sabah, Malaysia: High Proportion With Severe Disease From Plasmodium Knowlesi and Plasmodium Vivax But No Mortality With Early Referral and Artesunate Therapy

66 Use of Peroxisome Proliferator-Activated Receptor γ Agonists as Adjunctive Treatment for Plasmodium falciparum Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial

67 Antigen-Specific Immunosuppression in Human Malaria Due to Plasmodium falciparum

68 Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire

69 HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa

70 Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum

71 Plasmodium falciparum and helminth co-infection in a semi-urban population of pregnant women in Uganda

72 Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome

73 Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria

74 Plasmodium falciparum and helminth coinfection in a semi urban population of pregnant women in Uganda

75 assessment of clinical diagnosis, microscopy, rapid diagnostic tests, and polymerase chain reaction in the diagnosis of plasmodium falciparum in nigeria

76 delayed cerebellar ataxia: a rare self limiting complication of plasmodium falciparum malaria

77 hubungan kadar hemoglobin dengan respon sitokin proinflamasi dan anti inflamasi pada penderita infeksi plasmodium falciparum dan plasmodium vivax di timika, papua tahun 2010

78 sequence variation of pfemp1-dblα in association with rosette formation in <it>plasmodium falciparum </it>isolates causing severe and uncomplicated malaria

79 genetic polymorphism of merozoite surface protein 2 and prevalence of k76t <it>pfcrt </it>mutation in <it>plasmodium falciparum </it>field isolates from congolese children with asymptomatic infections

80 tratamento de 75 pacientes portadores de malária pelo p. falciparum, em porto velho (ro), com mefloquina

81 a gbp 130 derived peptide from plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro

82 molecular detection of plasmodium falciparum infection in matched peripheral and placental blood samples from delivering women in libreville, gabon

83 prevalence of plasmodium falciparum malaria among pregnant students in dodoma region, tanzania: no cases have been detected

84 how should antibodies against p. falciparum merozoite antigens be measured?

85 drug susceptibility of plasmodium falciparum in the western amazon region, state of acre, brazil susceptibilidade a droga, do plasmodium falciparum, na amazônia ocidental, estado do acre, brasil

86 chemoresistance of plasmodium falciparum and plasmodium vivax parasites in brazil: consequences on disease morbidity and control

87 chloroquine sensitivity of plasmodium falciparum in berakit, bintan island, sumatra, after mass chemoprophylaxis through community participation, and its sociological studies

88 efficacy of artesunate + sulphadoxine-pyrimethamine (as + sp) and amodiaquine + sulphadoxine-pyrimethamine (aq + sp) for uncomplicated falciparum malaria in equatorial guinea (central africa)

89 high plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of mali.

90 rapid whole genome optical mapping of <it>plasmodium falciparum</it>

91 mutations in plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the amazon region of brazil

92 malária não complicada por plasmodium vivax e p. falciparum no brasil: evidências sobre fármacos isolados e associações medicamentosas empregados em esquemas terapêuticos recomendados pelo protocolo terapêutico oficial uncomplicated plasmodium vivax and p. falciparum malaria in brazil: evidence on single and combined drug treatments recommended by official guidelines

93 resistência à mefloquina do tipo riii em crianças com malária falciparum em manaus, am, brasil riii mefloquine resistance in children with falciparum malaria in manaus, am, brazil

94 mutaciones puntuales en los genes dhfr y dhps de plasmodium falciparum de tres regiones endémicas

95 pfgbp: una proteína de unión al telómero de plasmodium falciparum

96 in vitro chloroquine resistance in plasmodium falciparum isolates from tertiary care hospital

97 in-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant plasmodium falciparum.

98 synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-plasmodium falciparum agents

99 effects of drug policy changes on evolution of molecular markers of plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the south west region of cameroon

100 gametocitemia en malaria por plasmodium falciparum tratada con amodiaquina o artesunato

101 plasmodium falciparum cs protein - prime malaria vaccine candidate: definition of the human ctl domain and analysis of its variation

Keyword Connections

Journals

Research Groups

Bibliographies